1. Home
  2. FSP vs NSRX Comparison

FSP vs NSRX Comparison

Compare FSP & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

N/A

Current Price

$0.41

Market Cap

33.3M

Sector

Real Estate

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$3.20

Market Cap

37.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSP
NSRX
Founded
1981
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
37.1M
IPO Year
2001
2024

Fundamental Metrics

Financial Performance
Metric
FSP
NSRX
Price
$0.41
$3.20
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $19.67
AVG Volume (30 Days)
★ 1.2M
16.3K
Earning Date
10-27-2026
08-17-2026
Dividend Yield
★ 2.60%
N/A
EPS Growth
★ 15.69
N/A
EPS
N/A
★ N/A
Revenue
★ $107,162,000.00
N/A
Revenue This Year
$16.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.30
$1.98
52 Week High
$1.28
$9.50

Technical Indicators

Market Signals
Indicator
FSP
NSRX
Relative Strength Index (RSI) 54.85 40.21
Support Level $0.42 $2.98
Resistance Level $0.51 $3.61
Average True Range (ATR) 0.05 0.27
MACD 0.00 -0.00
Stochastic Oscillator 59.51 18.33

Price Performance

Historical Comparison
FSP
NSRX

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: